key: cord-0952996-gvqt5z3d
authors: Singh, Rahul; Bhardwaj, Vijay Kumar; Das, Pralay; Purohit, Rituraj
title: A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2
date: 2021-06-08
journal: Comput Biol Med
DOI: 10.1016/j.compbiomed.2021.104555
sha: f4d2cf155570d96c1360bbaba5aba691f396abc4
doc_id: 952996
cord_uid: gvqt5z3d

BACKGROUND: Non-structural protein 1 (Nsp1), a virulence agent of SARS-CoV-2, has emerged as an important target for drug discovery. Nsp1 shuts down the host gene function by associating with the 40S ribosomal subunit. METHODS: Molecular interactions, drug-likeness, physiochemical property predictions, and robust molecular dynamics (MD) simulations were employed to discover novel Nsp1 inhibitors. In this study, we evaluated a series of molecules based on the plant (Cedrus deodara) derived α,β,γ-Himachalenes scaffolds. RESULTS: The results obtained from estimated affinity and ligand efficiency suggested that BCH10, BCH15, BCH16, and BCH17 could act as potential inhibitors of Nsp1. Moreover, MD simulations comprising various MD driven time-dependent analyses and thermodynamic free energy calculations also suggested stable protein-ligand complexes and strong interactions with the binding site. Furthermore, the selected molecules passed drug likeliness parameters and the physiochemical property analysis showed acceptable bioactivity scores. CONCLUSION: The structural parameters of dynamic simulations revealed that the reported molecules could act as lead compounds against SARS-CoV-2 Nsp1 protein.

It is the third time that the 21 st century is experiencing a coronavirus (CoV) outbreak. However, the 54 current pandemic is most endangering in terms of the global economy and health [1] [2] [3] . CoV First, it binds with the small ribosomal subunit and delays mRNA translation at several stages of 78 initiation [6, 11] . Secondly, the binding of Nsp1 to the ribosome directs the endonucleolytic divi-79 sion and host mRNA degradation [6] . Nsp1 of SARS-CoV-2 disrupts the mRNA export machinery 80 to inhibit host gene expression [12] . In addition, Nsp1 could be able to reduce cellular translation 81 considerably; however, remaining ribosomes would still be able to translate viral mRNAs with high 82 efficiency [5] . Besides, a new strain of SARS-CoV-2 was reported to lack specific amino acids 83 from Nsp1. The lack of these specific amino acids indicated profound genomic changes in SARS-84 

Molinspiration, an automatic server, was utilized for the molecular property prediction that divines 179 both pharmacological and physiochemical attributes such as LogP, molecular size, rotatable bonds, 180 and hydrogen bonding features (https://www.molinspiration.com). The molecules were converted 181 into SMILE format using OpenBabel server to analyze the molecular properties [44] . Recently, a crystallographic structure of Nsp1 was submitted to the PDB database. Howev-185 er, the structure was missing the residues of the C-terminal domain. Hence, we adopted the molecu-186 lar modeling approach to built the full length structure of Nsp1. Molecular modeling includes tac-187 tics (conceptual/computational) to reproduce a structure comparable to the original three-188 dimensional (3D) crystal structure. We first employed the SWISS-MODEL to build a full length 189 protein model by providing Nsp1 structure (PDB ID: 7K3N) as a template. However, SWISS-190 MODEL was not able to generate a full length model of Nsp1 protein. Further, we employed the I-191

TASSER server that uses a hierarchical path to predict the protein structure. The full length 3D 192 model of SARS-CoV-2 Nsp1 was developed, as displayed in Figure S1a . The predicted structure 193 was submitted to Github (https://github.com/Rahulbioinfo/Structural-Bionformatics-Lab.git). The 194 predicted model showed a -2.53 C-score with a 0.42±0.14 estimated TM-align score. The structure 195 validation was done on the basis of Ramachandran plot analysis. The Ramachandran plot of the 196 modeled protein confirmed that 92.5% and 96.4% of all residues were in the favored and allowed 197 areas respectively ( Figure S1b ). These results recommended that the predicted protein model was of 198 high-quality and appropriate for further in-silico studies. 199

The predicted full length model of Nsp1 was subjected to molecular docking. The "Find unoccupied 201 pocket" of SeeSAR was used to define the binding site of Nsp1. A total of five binding pockets 202 were produced using "Find unoccupied pocket" function of SeeSAR. The second binding pocket 203 containing 21 residues of the C-terminal region was considered for docking, while other pockets 204 were found away from the C-terminal area. 205

Molecular docking is a method that predicts the stable interaction profiles between a ligand 206 and a protein. The AABs analogues were docked with SARS-CoV-2 Nsp1 to estimate the character-207 istics of protein-ligand binding, including the binding affinity, LE, and Torsion (Table S1 ). Based 208 on these characteristics, BCH10 (N-((-6,7-dihydro-3,5,5-trimethyl-8phenyl5Hbenzo[7] annulen-9-209 yl)methyl)(phenyl)methan amine), BCH15 (1-Phenyl-N-((3,5,5-trimethyl-8-phenyl-6,7-dihydro-210 5H-benzo[7]annulen-9-yl)methyl)ethan amine), BCH16 (2-Methyl-N-((3,5,5-trimethyl-8-phenyl-211 6,7-dihydro-5H-benzo[7]annulen-9-yl)methyl)propan-2-amine), and BCH17 (N-((3,5,5-trimethyl-8-212 phenyl-6,7-dihydro-5H-benzo[7]annulen-9-yl)methyl)propan-2-amine) molecules were selected 213 from seventeen AAB molecules. Molecular docking results were presented in Table 1 . The docking 214 poses were produced from the PLIP server. In complex with Nsp1 molecules, BCH10, BCH15, 215 BCH16, and BCH17 showed hydrophobic interactions with key residues Phe143, Phe157, and 216

Gln158 of C-terminal domain. Other residues involved in hydrophobic interactions were Val35, 217

Glu36, Leu39, Val89, and Tyr97. H-bonds bonds were observed only in Nsp1-BCH17 complex. 218

The residues involved in H-bonds were Asp156 and Phe157 ( Figure 2) . Nsp1 by I-TASSER server that showed 92.5% and 96.4% of all residues in the favored and allowed 294 regions, respectively. The models with more than 88% of amino acids in the allowed region of Ra-295 machandran plot are considered for computational studies. Additionally, we also validated our pre-296 dicted model by superimposing it with the newly deposited Nsp1 structure of SARS-CoV-2 and 297 template structure (Nsp1 of SARS-Co-V) as depicted in Figure S4 . The superimposition outcome 298 showed 0.3 Å RMSD between all the compared structures. The low RMSD values reaffirmed that 299 the predicted structure was robust and not producing any discrepancy. 300 Already published studies in well reputed journals proclaimed that the C-terminal region of SARS-301

CoV-2 Nsp1 containing 143-180 residues perform an essential role in the inhibition of host protein 302 synthesis [5, 6, 45]. Hence, we adopted a similar binding site (C-terminal region) for docking pre-303 dicted by the "Find unoccupied pocket" of SeeSAR. The "Find unoccupied pocket" is made on a 304 heuristic prototype that utilizes the Gaussian variations on a 3-D grid to search the probability of 305 administering with a pocket pattern. Furthermore, other notable parameters, such as the global H-306 bond features, lipophilic nature, and the hypothetical pockets solvent accessible surface area, were 307 also acknowledged. Moreover, the prediction was additionally improved with local actions such as 308 ranges between sets of functional group atoms. Thus, the binding site similarity between existing 309 literature and our predicted site strengthened our proposed approach. 310

From molecular docking, best four docked complexes were selected based on LE, Estimated 311 affinity, and torsion (Table 1) Table S2 and Figure S3 . 364 Further, to acquire the Gibb's free energy, 2D and 3D FEL plots were generated, as shown 365

in Figure 5 . The energy range for BCH10 and BCH17 was between 0 and 28.20 kJ/mol, while for 366 the BCH15 and BCH16 the value ranges from 0 to 27.40 kJ/mol. Over higher free energy space 367 with deep basins, the violet color localities symbolized the local energy minima and actively fa-368 vored conformations ( Figure 5 ). The FEL approach revealed that all the complexes were highly sta-369 ble. The protein-ligand poses were extracted from their respective minima states and subjected to 370 geometrical shape analysis of the binding cavity. The decrease in cavity space showed stable and 371 deep attachment of molecules in the cavity. The geometrical shape analysis results further comple-372 mented our binding free energy analysis. 373

The MD driven results suggested that the selected molecules could be developed to target 374 the binding site of Nsp1 protein of SARS-CoV-2. Hence, we calculated the pharmaceutical and 375 physiochemical properties of these molecules. These attributes were estimated on the basis of 376

Lipinski's Rule of Five that predicts the drug-likeness and recognizes the pharmacological action 377 that would support the making of an excellent orally effective drug [54, 55] . All the selected mole-378 cules passed the criteria of rule of five. Moreover, we also accessed the bioavailability of selected 379 molecules through molinspiration server. The molinspiration server compares the molecules with an 380 average number of 100000 drug-like molecules, and the bioactivity score permits adequate separa-381 tion of inactive and active molecules. The physiochemical results showed that all the selected mole-382 cules were biologically active. To conclude, the selected top four molecules demonstrated feasible 383 drug-like properties and considerable bioavailability to be developed as therapeutic agents. 

There are no competing interests declared by the authors. 399 

Structural basis of receptor recognition by SARS-CoV-2. 407

Structure, Function, and Antigenicity of the 409 SARS-CoV-2 Spike Glycoprotein

A highly conserved cryptic epitope in the receptor 412 binding domains of SARS-CoV-2 and SARS-CoV

The Molecular Biology of Coronaviruses

SARS-CoV-2 Nsp1 binds the ribosomal 416 mRNA channel to inhibit translation

Structural basis for translational shut-419 down and immune evasion by the Nsp1 protein of SARS-CoV-2

SARS-CoV-2 nsp1: Bioinformatics, Potential Struc-422 tural and Functional Features, and Implications for Drug/Vaccine Designs

Analysis of therapeutic targets for SARS-CoV-2 and dis-425 covery of potential drugs by computational methods

Structural characterization of nonstructural 428 protein 1 from SARS-CoV-2. iScience 24:101903

drome Coronavirus Protein nsp1 Is a Novel Eukaryotic Translation Inhibitor That Represses 433

Multiple Steps of Translation Initiation

Nsp1 protein of SARS-CoV-2 disrupts the mRNA 436 export machinery to inhibit host gene expression

Emerging of a SARS-CoV-2 viral strain 439 with a deletion in nsp1

Severe Acute Respiratory Syndrome

Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in 442 Infected Cells

Therapeutic options for the 2019 novel coronavirus

Identification of bioactive molecules from tea 446 plant as SARS-CoV-2 main protease inhibitors

An in-silico evaluation of different bio-449 active molecules of Tea for their inhibition potency against non structural protein-15 of 450 SARS-CoV-2

Evaluation of acridinedione analogs as po-452 tential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-453 viral drugs

Depicting the inhibitory potential 456 of polyphenols from Isatis indigotica root against the main protease of SARS CoV-2 using 457 computational approaches

Justicia adhatoda as potent SARS CoV-2 main protease inhibitors: An in silico perspective

Reckoning γ-Glutamyl-S-allylcysteine as a po-463 tential Main protease (M pro ) inhibitor of novel SARS-CoV-2 virus identified using docking 464 and molecular dynamics simulation

Bioactive molecules of Tea as potential inhib-467 itors for RNA-dependent RNA polymerase of SARS-CoV-2. Front Med 8:645

In-silico evaluation of bioactive compounds 470 from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors

Phytochemical analysis and in vitro evaluation of 473 the biological activity against herpes simplex virus type 1 (HSV-1) of Cedrus libani A. Rich

Phytochemical and pharmacological proper-476 ties of essential oils from Cedrus species

Antiviral properties of phytochemicals

Suzuki-Miyaura cross-coupling approach for synthesis of aminoarylbenzosuberene ana-481 logues from natural precursor

Efficient Geometry Minimization and Transition Structure Opti-485 mization Using Interpolated Potential Energy Surfaces and Iteratively Updated Hessians

I-TASSER server for protein 3D structure prediction

A consistent description of HYdrogen bond 490 and DEhydration energies in protein-ligand complexes: Methods behind the HYDE scoring 491 function

Towards an integrated description of hydrogen 493 bonding and dehydration: Decreasing false positives in virtual screening with the HYDE 494 scoring function

The maximal affinity of ligands

PLIP: Fully automated protein-ligand interac-498 tion profiler

Identification of small molecules against cyclin dependent ki-500 nase-5 using chemoinformatics approach for Alzheimer's disease and other tauopathies

Gromacs: High performance molecular 503 simulations through multi-level parallelism from laptops to supercomputers

Algorithms for high-506 ly efficient, load-balanced, and scalable molecular simulation

GROMACS: Fast, flexible, and free

PRODRG: A tool for high-throughput crystal-511 lography of protein-ligand complexes

LINCS: A Linear Constraint Solv-514 er for molecular simulations

Particle mesh Ewald: An N·log(N) method for Ewald 517 sums in large systems

G-mmpbsa -A GROMACS tool for high-throughput 521 MM-PBSA calculations

Open Babel: An Open chemical toolbox

Identification of potential drugs against SARS-526

CoV-2 non-structural protein 1 (nsp1)

Ligand efficiency: A useful metric for lead selec-529 tion

Torsion angle preferences in druglike 531 chemical space: A comprehensive guide

Hossain A (2020) A Computational Approach for Identifying Potential Phytochemicals 534

Against Non-structural Protein 1 (Nsp1) of SARS-CoV-2

Structure of the SARS-CoV-2 Nsp1

Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, 538 and Virulence

Structural changes induced by substitution of amino acid 540 129 in the coat protein of Cucumber mosaic virus

Computational search for potential COVID-19 543 drugs from FDA-approved drugs and small molecules of natural origin identifies several anti-544 virals and plant products

Structural based study to identify new poten-546 tial inhibitors for dual specificity tyrosine-phosphorylation-regulated kinase

Identification of selective cyclin-dependent 549

kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico 550 exploration

An Industry 553 Perspective from the International Consortium for Innovation through Quality in Pharmaceu-554 tical Development

Fast calculation of molecular polar surface area as a sum of 556 fragment-based contributions and its application to the prediction of drug transport properties

The 3D interaction poses of the Nsp1 binding site. (a) BCH10, (b) BCH15, (c)BCH16, 599 and (d)

RMSDs of backbone C-α-atoms are shown as a function of time of the Nsp1 609 complexes. (b) Graphical representation of RMSF for the backbone C-α-atoms of Nsp1 complexes. 610 (c) Change in Rg of the Nsp1 protein complexes. (d) The analysis of Hydrogen bonds formed be-611 tween protein-ligand during the simulation. The symbol coding scheme is as follows: BCH10 (red 612 color)

Acknowledgment